{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:34:40Z","timestamp":1787020480714,"version":"build-2736575974"},"reference-count":220,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Jiangsu Province Excellent Postdoctoral Program","award":["No.2024ZB240"],"award-info":[{"award-number":["No.2024ZB240"]}]},{"name":"the Technology Project of Zhangjiagang","award":["ZKYL2331"],"award-info":[{"award-number":["ZKYL2331"]}]},{"name":"the Technology Project of Zhangjiagang","award":["ZKYL2228"],"award-info":[{"award-number":["ZKYL2228"]}]},{"name":"Research fund project of Jiangsu Medical Association","award":["SYH-3201160\u20130055(2023002)"],"award-info":[{"award-number":["SYH-3201160\u20130055(2023002)"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82272179"],"award-info":[{"award-number":["No.82272179"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Innovation Foundation for Medicine and Education Synergy of Jiangsu University","award":["JDY2022020"],"award-info":[{"award-number":["JDY2022020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Small extracellular vesicles (sEVs) play a critical role in the progression, diagnosis, and treatment of prostate cancer (PCa), particularly within the tumor microenvironment (TME). Acting as novel biomarkers and agents for targeted biological therapy, sEVs contribute significantly to improving patient survival. These vesicles transport a variety of biomolecules, including proteins, nucleic acids, and lipids, which are instrumental in remodeling the TME, facilitating intercellular communication, and influencing key processes such as tumor growth, metastasis, and therapy resistance. A thorough understanding of sEV heterogeneity, including their biogenesis, characteristics, and potential applications, is essential. Recent advances have illuminated the origins, formation processes, and molecular cargo of PCa-derived sEVs (PCa-sEVs), enhancing our understanding of their role in disease progression. Furthermore, sEVs show promise as diagnostic markers, with potential applications in early detection and prognostic assessment in PCa. Therapeutically, natural and engineered sEVs offer versatile applications, including drug delivery, gene therapy, and immunomodulation, underscoring their potential in PCa management. This review delves into the substantial potential of sEVs in clinical practices for PCa.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s12951-025-03326-w","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T22:25:16Z","timestamp":1742509516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Small extracellular vesicles: crucial mediators for prostate cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Sijie","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongli","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"issue":"3","key":"3326_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3326_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10555-024-10168-9","volume":"43","author":"M Ashrafizadeh","year":"2024","unstructured":"Ashrafizadeh M, Zhang W, Tian Y, Sethi G, Zhang X, Qiu A. Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation. Cancer Metastasis Rev. 2024;43(1):229\u201360.","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"3326_CR3","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s13046-022-02406-1","volume":"41","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei S, Paskeh MDA, Okina E, Gholami MH, Hushmandi K, Hashemi M, et al. Molecular landscape of LncRNAs in prostate cancer: A focus on pathways and therapeutic targets for intervention. J Exp Clin Cancer Res. 2022;41(1):214.","journal-title":"J Exp Clin Cancer Res"},{"key":"3326_CR4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ijbiomac.2022.02.094","volume":"206","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei S, Paskeh MDA, Saghari Y, Zarrabi A, Hamblin MR, Entezari M, et al. Transforming growth factor-beta (TGF-beta) in prostate cancer: A dual function mediator? Int J Biol Macromol. 2022;206:435\u201352.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"3326_CR5","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/s12951-023-02219-0","volume":"21","author":"H Chen","year":"2023","unstructured":"Chen H, Pang B, Zhou C, Han M, Gong J, Li Y, et al. Prostate cancer-derived small extracellular vesicle proteins: the hope in diagnosis, prognosis, and therapeutics. J Nanobiotechnol. 2023;21(1):480.","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"3326_CR6","doi-asserted-by":"publisher","first-page":"e12042","DOI":"10.1002\/jev2.12042","volume":"10","author":"SE Henrich","year":"2020","unstructured":"Henrich SE, McMahon KM, Plebanek MP, Calvert AE, Feliciano TJ, Parrish S, et al. Prostate cancer extracellular vesicles mediate intercellular communication with bone marrow cells and promote metastasis in a cholesterol-dependent manner. J Extracell Vesicles. 2020;10(2):e12042.","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"3326_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12964-021-00792-1","volume":"19","author":"P Giovannelli","year":"2021","unstructured":"Giovannelli P, Di Donato M, Galasso G, Monaco A, Licitra F, Perillo B, et al. Communication between cells: exosomes as a delivery system in prostate cancer. Cell Commun Signal. 2021;19(1):110.","journal-title":"Cell Commun Signal"},{"issue":"8","key":"3326_CR8","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.cell.2023.03.016","volume":"186","author":"Y Chhabra","year":"2023","unstructured":"Chhabra Y, Weeraratna AT. Fibroblasts in cancer: unity in heterogeneity. Cell. 2023;186(8):1580\u2013609.","journal-title":"Cell"},{"issue":"12","key":"3326_CR9","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.trecan.2019.10.007","volume":"5","author":"K Mehla","year":"2019","unstructured":"Mehla K, Singh PK. Metabolic regulation of macrophage polarization in cancer. Trends Cancer. 2019;5(12):822\u201334.","journal-title":"Trends Cancer"},{"issue":"1","key":"3326_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41392-024-01765-9","volume":"9","author":"A Hu","year":"2024","unstructured":"Hu A, Sun L, Lin H, Liao Y, Yang H, Mao Y. Harnessing innate immune pathways for therapeutic advancement in cancer. Signal Transduct Target Ther. 2024;9(1):68.","journal-title":"Signal Transduct Target Ther"},{"key":"3326_CR11","doi-asserted-by":"publisher","first-page":"1007360","DOI":"10.3389\/fcell.2022.1007360","volume":"10","author":"D Huang","year":"2022","unstructured":"Huang D, Rao D, Xi X, Zhang Z, Zhong T. Application of extracellular vesicles proteins in cancer diagnosis. Front Cell Dev Biol. 2022;10:1007360.","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"3326_CR12","doi-asserted-by":"publisher","first-page":"2102620","DOI":"10.1002\/advs.202102620","volume":"9","author":"Y Yin","year":"2022","unstructured":"Yin Y, Liu B, Cao Y, Yao S, Liu Y, Jin G, et al. Colorectal cancer-derived small extracellular vesicles promote tumor immune evasion by upregulating PD-L1 expression in tumor-associated macrophages. Adv Sci (Weinh). 2022;9(9):2102620.","journal-title":"Adv Sci (Weinh)"},{"key":"3326_CR13","doi-asserted-by":"crossref","unstructured":"Seibold T, Waldenmaier M, Seufferlein T, Eiseler T. Small extracellular vesicles and metastasis-blame the messenger. Cancers (Basel). 2021;13(17).","DOI":"10.3390\/cancers13174380"},{"key":"3326_CR14","doi-asserted-by":"publisher","first-page":"1270104","DOI":"10.3389\/fonc.2023.1270104","volume":"13","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, Zhou Y, Li H, Xu W, Wang T, Liu J, et al. Research trends and hotspots in prostate cancer associated exosome: a bibliometric analysis. Front Oncol. 2023;13:1270104.","journal-title":"Front Oncol"},{"issue":"11","key":"3326_CR15","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1158\/1078-0432.CCR-20-4790","volume":"27","author":"I Vardaki","year":"2021","unstructured":"Vardaki I, Corn P, Gentile E, Song JH, Madan N, Hoang A, et al. Radium-223 treatment increases immune checkpoint expression in extracellular vesicles from the metastatic prostate cancer bone microenvironment. Clin Cancer Res. 2021;27(11):3253\u201364.","journal-title":"Clin Cancer Res"},{"key":"3326_CR16","doi-asserted-by":"crossref","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478).","DOI":"10.1126\/science.aau6977"},{"issue":"4","key":"3326_CR17","doi-asserted-by":"publisher","first-page":"e12068","DOI":"10.1002\/jev2.12068","volume":"10","author":"Q Ma","year":"2021","unstructured":"Ma Q, Liang M, Wu Y, Dou C, Xu J, Dong S, et al. Small extracellular vesicles deliver osteolytic effectors and mediate cancer-induced osteolysis in bone metastatic niche. J Extracell Vesicles. 2021;10(4):e12068.","journal-title":"J Extracell Vesicles"},{"issue":"23","key":"3326_CR18","doi-asserted-by":"publisher","first-page":"e2402509","DOI":"10.1002\/advs.202402509","volume":"11","author":"B Pang","year":"2024","unstructured":"Pang B, Wang Q, Chen H, Liu Z, Han M, Gong J, et al. Proteomic identification of small extracellular vesicle proteins LAMB1 and histone H4 for prostate cancer diagnosis and risk stratification. Adv Sci (Weinh). 2024;11(23):e2402509.","journal-title":"Adv Sci (Weinh)"},{"key":"3326_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.isci.2019.03.022","volume":"14","author":"RM DeRita","year":"2019","unstructured":"DeRita RM, Sayeed A, Garcia V, Krishn SR, Shields CD, Sarker S, et al. Tumor-derived extracellular vesicles require beta1 integrins to promote anchorage-independent growth. iScience. 2019;14:199\u2013209.","journal-title":"iScience"},{"issue":"3","key":"3326_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41416-021-01610-8","volume":"126","author":"M Ramirez-Garrastacho","year":"2022","unstructured":"Ramirez-Garrastacho M, Bajo-Santos C, Line A, Martens-Uzunova ES, de la Fuente JM, Moros M, et al. Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research. Br J Cancer. 2022;126(3):331\u201350.","journal-title":"Br J Cancer"},{"key":"3326_CR21","doi-asserted-by":"crossref","unstructured":"Inder KL, Ruelcke JE, Petelin L, Moon H, Choi E, Rae J, et al. Cavin-1\/PTRF alters prostate cancer cell-derived extracellular vesicle content and internalization to attenuate extracellular vesicle-mediated osteoclastogenesis and osteoblast proliferation. J Extracell Vesicles. 2014;3.","DOI":"10.3402\/jev.v3.23784"},{"issue":"Pt B","key":"3326_CR22","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jconrel.2015.09.031","volume":"220","author":"H Saari","year":"2015","unstructured":"Saari H, Lazaro-Ibanez E, Viitala T, Vuorimaa-Laukkanen E, Siljander P, Yliperttula M. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells. J Control Release. 2015;220(Pt B):727\u201337.","journal-title":"J Control Release"},{"issue":"13","key":"3326_CR23","doi-asserted-by":"publisher","first-page":"6526","DOI":"10.7150\/thno.53886","volume":"11","author":"Q Han","year":"2021","unstructured":"Han Q, Xie QR, Li F, Cheng Y, Wu T, Zhang Y, et al. Targeted Inhibition of SIRT6 via engineered exosomes impairs tumorigenesis and metastasis in prostate cancer. Theranostics. 2021;11(13):6526\u201341.","journal-title":"Theranostics"},{"key":"3326_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jconrel.2019.12.032","volume":"319","author":"P Zhupanyn","year":"2020","unstructured":"Zhupanyn P, Ewe A, Buch T, Malek A, Rademacher P, Muller C, et al. Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced SiRNA delivery in vitro and in vivo. J Control Release. 2020;319:63\u201376.","journal-title":"J Control Release"},{"issue":"1","key":"3326_CR25","doi-asserted-by":"publisher","first-page":"20924","DOI":"10.1038\/s41598-022-23204-x","volume":"12","author":"A Rezaeian","year":"2022","unstructured":"Rezaeian A, Khatami F, Heidari Keshel S, Akbari MR, Mirzaei A, Gholami K, et al. The effect of mesenchymal stem cells-derived exosomes on the prostate, bladder, and renal cancer cell lines. Sci Rep. 2022;12(1):20924.","journal-title":"Sci Rep"},{"key":"3326_CR26","doi-asserted-by":"crossref","unstructured":"Valiunas V, Gordon C, Valiuniene L, Devine D, Lin RZ, Cohen IS, et al. Intercellular delivery of therapeutic oligonucleotides. J Drug Deliv Sci Technol. 2022;72.","DOI":"10.1016\/j.jddst.2022.103404"},{"issue":"15","key":"3326_CR27","doi-asserted-by":"publisher","first-page":"e2103222","DOI":"10.1002\/advs.202103222","volume":"9","author":"JJ Lai","year":"2022","unstructured":"Lai JJ, Chau ZL, Chen SY, Hill JJ, Korpany KV, Liang NW, et al. Exosome processing and characterization approaches for research and technology development. Adv Sci (Weinh). 2022;9(15):e2103222.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"3326_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12866-023-02945-3","volume":"23","author":"A Ullah","year":"2023","unstructured":"Ullah A, Huang Y, Zhao K, Hua Y, Ullah S, Rahman MU, et al. Characteristics and potential clinical applications of the extracellular vesicles of human pathogenic fungi. BMC Microbiol. 2023;23(1):227.","journal-title":"BMC Microbiol"},{"issue":"1","key":"3326_CR29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41392-020-00258-9","volume":"5","author":"B Zhou","year":"2020","unstructured":"Zhou B, Xu K, Zheng X, Chen T, Wang J, Song Y, et al. Application of exosomes as liquid biopsy in clinical diagnosis. Signal Transduct Target Ther. 2020;5(1):144.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"3326_CR30","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ceb.2009.03.007","volume":"21","author":"M Simons","year":"2009","unstructured":"Simons M, Raposo G. Exosomes\u2013vesicular carriers for intercellular communication. Curr Opin Cell Biol. 2009;21(4):575\u201381.","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"3326_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13045-019-0739-0","volume":"12","author":"Q Wu","year":"2019","unstructured":"Wu Q, Zhou L, Lv D, Zhu X, Tang H. Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression. J Hematol Oncol. 2019;12(1):53.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"3326_CR32","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1080\/15548627.2020.1820787","volume":"17","author":"N Ariotti","year":"2021","unstructured":"Ariotti N, Wu Y, Okano S, Gambin Y, Follett J, Rae J, et al. An inverted CAV1 (caveolin 1) topology defines novel autophagy-dependent exosome secretion from prostate cancer cells. Autophagy. 2021;17(9):2200\u201316.","journal-title":"Autophagy"},{"issue":"1","key":"3326_CR33","doi-asserted-by":"publisher","first-page":"8161","DOI":"10.1038\/s41598-018-26411-7","volume":"8","author":"A Datta","year":"2018","unstructured":"Datta A, Kim H, McGee L, Johnson AE, Talwar S, Marugan J, et al. High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: a drug repurposing strategy for advanced cancer. Sci Rep. 2018;8(1):8161.","journal-title":"Sci Rep"},{"issue":"1","key":"3326_CR34","doi-asserted-by":"publisher","first-page":"183007","DOI":"10.1016\/j.bbamem.2019.06.006","volume":"1862","author":"DW Hilgemann","year":"2020","unstructured":"Hilgemann DW, Lin MJ, Fine M, Deisl C. On the existence of endocytosis driven by membrane phase separations. Biochim Biophys Acta Biomembr. 2020;1862(1):183007.","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"3326_CR35","doi-asserted-by":"crossref","unstructured":"Liu XM, Ma L, Schekman R. Selective sorting of MicroRNAs into exosomes by phase-separated YBX1 condensates. Elife. 2021;10.","DOI":"10.7554\/eLife.71982"},{"issue":"8","key":"3326_CR36","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.cell.2023.03.010","volume":"186","author":"R Kalluri","year":"2023","unstructured":"Kalluri R, McAndrews KM. The role of extracellular vesicles in cancer. Cell. 2023;186(8):1610\u201326.","journal-title":"Cell"},{"issue":"12","key":"3326_CR37","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/s41556-021-00805-8","volume":"23","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Jeppesen DK, Higginbotham JN, Graves-Deal R, Trinh VQ, Ramirez MA, et al. Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets. Nat Cell Biol. 2021;23(12):1240\u201354.","journal-title":"Nat Cell Biol"},{"key":"3326_CR38","doi-asserted-by":"crossref","unstructured":"Huang D, Sun G, Hao X, He X, Zheng Z, Chen C, et al. ANGPTL2-containing small extracellular vesicles from vascular endothelial cells accelerate leukemia progression. J Clin Invest. 2021;131(1).","DOI":"10.1172\/JCI138986"},{"issue":"1","key":"3326_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cmet.2020.06.004","volume":"32","author":"JA Fafian-Labora","year":"2020","unstructured":"Fafian-Labora JA, Rodriguez-Navarro JA, O\u2019Loghlen A. Small extracellular vesicles have GST activity and ameliorate senescence-related tissue damage. Cell Metab. 2020;32(1):71\u201386. e5.","journal-title":"Cell Metab"},{"issue":"12","key":"3326_CR40","doi-asserted-by":"publisher","first-page":"e12287","DOI":"10.1002\/jev2.12287","volume":"11","author":"D Jung","year":"2022","unstructured":"Jung D, Shin S, Kang SM, Jung I, Ryu S, Noh S, et al. Reprogramming of T cell-derived small extracellular vesicles using IL2 surface engineering induces potent anti-cancer effects through MiRNA delivery. J Extracell Vesicles. 2022;11(12):e12287.","journal-title":"J Extracell Vesicles"},{"issue":"7","key":"3326_CR41","doi-asserted-by":"publisher","first-page":"e12342","DOI":"10.1002\/jev2.12342","volume":"12","author":"X Wang","year":"2023","unstructured":"Wang X, Xu F, Kou H, Zheng Y, Yang J, Xu Z, et al. Stromal cell-derived small extracellular vesicles enhance radioresistance of prostate cancer cells via interleukin-8-induced autophagy. J Extracell Vesicles. 2023;12(7):e12342.","journal-title":"J Extracell Vesicles"},{"issue":"12","key":"3326_CR42","doi-asserted-by":"publisher","first-page":"9729","DOI":"10.1002\/jcp.29784","volume":"235","author":"H Guan","year":"2020","unstructured":"Guan H, Peng R, Fang F, Mao L, Chen Z, Yang S, et al. Tumor-associated macrophages promote prostate cancer progression via exosome-mediated miR-95 transfer. J Cell Physiol. 2020;235(12):9729\u201342.","journal-title":"J Cell Physiol"},{"issue":"3","key":"3326_CR43","doi-asserted-by":"publisher","first-page":"e12056","DOI":"10.1002\/jev2.12056","volume":"10","author":"L Yu","year":"2021","unstructured":"Yu L, Sui B, Fan W, Lei L, Zhou L, Yang L, et al. Exosomes derived from osteogenic tumor activate osteoclast differentiation and concurrently inhibit osteogenesis by transferring COL1A1-targeting miRNA-92a-1-5p. J Extracell Vesicles. 2021;10(3):e12056.","journal-title":"J Extracell Vesicles"},{"issue":"10","key":"3326_CR44","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1038\/sj.bjc.6605058","volume":"100","author":"J Nilsson","year":"2009","unstructured":"Nilsson J, Skog J, Nordstrand A, Baranov V, Mincheva-Nilsson L, Breakefield XO, et al. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br J Cancer. 2009;100(10):1603\u20137.","journal-title":"Br J Cancer"},{"key":"3326_CR45","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.canlet.2017.06.036","volume":"403","author":"M Logozzi","year":"2017","unstructured":"Logozzi M, Angelini DF, Iessi E, Mizzoni D, Di Raimo R, Federici C, et al. Increased PSA expression on prostate cancer exosomes in in vitro condition and in cancer patients. Cancer Lett. 2017;403:318\u201329.","journal-title":"Cancer Lett"},{"issue":"8","key":"3326_CR46","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1007\/s00432-022-04391-6","volume":"149","author":"WWY Choi","year":"2023","unstructured":"Choi WWY, Sanchez C, Li JJ, Dinarvand M, Adomat H, Ghaffari M, et al. Extracellular vesicles from biological fluids as potential markers in castration resistant prostate cancer. J Cancer Res Clin Oncol. 2023;149(8):4701\u201317.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"3326_CR47","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1002\/jcb.28239","volume":"121","author":"T Li","year":"2020","unstructured":"Li T, Sun X, Chen L. Exosome circ_0044516 promotes prostate cancer cell proliferation and metastasis as a potential biomarker. J Cell Biochem. 2020;121(3):2118\u201326.","journal-title":"J Cell Biochem"},{"issue":"sup3","key":"3326_CR48","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1080\/21691401.2018.1489263","volume":"46","author":"J Lee","year":"2018","unstructured":"Lee J, Kwon MH, Kim JA, Rhee WJ. Detection of exosome MiRNAs using molecular beacons for diagnosing prostate cancer. Artif Cells Nanomed Biotechnol. 2018;46(sup3):S52\u201363.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"14","key":"3326_CR49","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1002\/pros.22853","volume":"74","author":"E Lazaro-Ibanez","year":"2014","unstructured":"Lazaro-Ibanez E, Sanz-Garcia A, Visakorpi T, Escobedo-Lucea C, Siljander P, Ayuso-Sacido A, et al. Different gDNA content in the subpopulations of prostate cancer extracellular vesicles: apoptotic bodies, microvesicles, and exosomes. Prostate. 2014;74(14):1379\u201390.","journal-title":"Prostate"},{"key":"3326_CR50","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ejca.2016.10.011","volume":"70","author":"T Skotland","year":"2017","unstructured":"Skotland T, Ekroos K, Kauhanen D, Simolin H, Seierstad T, Berge V, et al. Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers. Eur J Cancer. 2017;70:122\u201332.","journal-title":"Eur J Cancer"},{"issue":"1","key":"3326_CR51","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12943-024-01932-0","volume":"23","author":"C Zhang","year":"2024","unstructured":"Zhang C, Qin C, Dewanjee S, Bhattacharya H, Chakraborty P, Jha NK, et al. Tumor-derived small extracellular vesicles in cancer invasion and metastasis: molecular mechanisms, and clinical significance. Mol Cancer. 2024;23(1):18.","journal-title":"Mol Cancer"},{"key":"3326_CR52","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.semcancer.2019.09.004","volume":"62","author":"V Mohan","year":"2020","unstructured":"Mohan V, Das A, Sagi I. Emerging roles of ECM remodeling processes in cancer. Semin Cancer Biol. 2020;62:192\u2013200.","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"3326_CR53","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41556-023-01092-1","volume":"25","author":"B Wu","year":"2023","unstructured":"Wu B, Liu DA, Guan L, Myint PK, Chin L, Dang H, et al. Stiff matrix induces exosome secretion to promote tumour growth. Nat Cell Biol. 2023;25(3):415\u201324.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"3326_CR54","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/onc.2013.560","volume":"34","author":"JP Webber","year":"2015","unstructured":"Webber JP, Spary LK, Sanders AJ, Chowdhury R, Jiang WG, Steadman R, et al. Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes. Oncogene. 2015;34(3):290\u2013302.","journal-title":"Oncogene"},{"key":"3326_CR55","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.matbio.2018.05.002","volume":"78\u201379","author":"CO McAtee","year":"2019","unstructured":"McAtee CO, Booth C, Elowsky C, Zhao L, Payne J, Fangman T, et al. Prostate tumor cell exosomes containing hyaluronidase Hyal1 stimulate prostate stromal cell motility by engagement of FAK-mediated integrin signaling. Matrix Biol. 2019;78\u201379:165\u201379.","journal-title":"Matrix Biol"},{"issue":"1","key":"3326_CR56","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","volume":"11","author":"J Winkler","year":"2020","unstructured":"Winkler J, Abisoye-Ogunniyan A, Metcalf KJ, Werb Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat Commun. 2020;11(1):5120.","journal-title":"Nat Commun"},{"issue":"7","key":"3326_CR57","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/mc.22124","volume":"54","author":"A Ramteke","year":"2015","unstructured":"Ramteke A, Ting H, Agarwal C, Mateen S, Somasagara R, Hussain A, et al. Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules. Mol Carcinog. 2015;54(7):554\u201365.","journal-title":"Mol Carcinog"},{"key":"3326_CR58","doi-asserted-by":"publisher","first-page":"110126","DOI":"10.1016\/j.cellsig.2021.110126","volume":"87","author":"AN Prigol","year":"2021","unstructured":"Prigol AN, Rode MP, Silva AH, Cisilotto J, Creczynski-Pasa TB. Pro-angiogenic effect of PC-3 exosomes in endothelial cells in vitro. Cell Signal. 2021;87:110126.","journal-title":"Cell Signal"},{"issue":"8","key":"3326_CR59","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41419-023-06007-4","volume":"14","author":"JQ Luo","year":"2023","unstructured":"Luo JQ, Yang TW, Wu J, Lai HH, Zou LB, Chen WB, et al. Exosomal PGAM1 promotes prostate cancer angiogenesis and metastasis by interacting with ACTG1. Cell Death Dis. 2023;14(8):502.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3326_CR60","doi-asserted-by":"publisher","first-page":"1763594","DOI":"10.1080\/20013078.2020.1763594","volume":"9","author":"SR Krishn","year":"2020","unstructured":"Krishn SR, Salem I, Quaglia F, Naranjo NM, Agarwal E, Liu Q, et al. The \u0391v\u03b26 integrin in cancer cell-derived small extracellular vesicles enhances angiogenesis. J Extracell Vesicles. 2020;9(1):1763594.","journal-title":"J Extracell Vesicles"},{"key":"3326_CR61","doi-asserted-by":"crossref","unstructured":"Elaimy AL, Mercurio AM. Convergence of VEGF and YAP\/TAZ signaling: implications for angiogenesis and cancer biology. Sci Signal. 2018;11(552).","DOI":"10.1126\/scisignal.aau1165"},{"issue":"1","key":"3326_CR62","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12943-020-01208-3","volume":"19","author":"M Xie","year":"2020","unstructured":"Xie M, Yu T, Jing X, Ma L, Fan Y, Yang F, et al. Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p\/HUR\/VEGF axis and suppressing HSP90 degradation. Mol Cancer. 2020;19(1):112.","journal-title":"Mol Cancer"},{"issue":"1","key":"3326_CR63","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s13046-018-0965-2","volume":"37","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Ren H, Dai B, Li J, Shang L, Huang J, et al. Hepatocellular carcinoma-derived Exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts. J Exp Clin Cancer Res. 2018;37(1):324.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"3326_CR64","doi-asserted-by":"publisher","first-page":"715","DOI":"10.18632\/oncotarget.2711","volume":"6","author":"R Chowdhury","year":"2015","unstructured":"Chowdhury R, Webber JP, Gurney M, Mason MD, Tabi Z, Clayton A. Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblasts. Oncotarget. 2015;6(2):715\u201331.","journal-title":"Oncotarget"},{"key":"3326_CR65","doi-asserted-by":"crossref","unstructured":"Pudova E, Kobelyatskaya A, Katunina I, Snezhkina A, Nyushko K, Fedorova M, et al. Docetaxel resistance in castration-resistant prostate cancer: transcriptomic determinants and the effect of inhibiting Wnt\/beta-catenin signaling by XAV939. Int J Mol Sci. 2022;23(21).","DOI":"10.3390\/ijms232112837"},{"issue":"18","key":"3326_CR66","doi-asserted-by":"publisher","first-page":"6282","DOI":"10.1002\/cam4.4168","volume":"10","author":"S Zhu","year":"2021","unstructured":"Zhu S, Ni Y, Sun G, Wang Z, Chen J, Zhang X, et al. Exosomal TUBB3 mRNA expression of metastatic castration-resistant prostate cancer patients: association with patient outcome under abiraterone. Cancer Med. 2021;10(18):6282\u201390.","journal-title":"Cancer Med"},{"key":"3326_CR67","doi-asserted-by":"publisher","first-page":"1021270","DOI":"10.3389\/fonc.2022.1021270","volume":"12","author":"H Guan","year":"2022","unstructured":"Guan H, Mao L, Wang J, Wang S, Yang S, Wu H, et al. Exosomal RNF157 mRNA from prostate cancer cells contributes to M2 macrophage polarization through destabilizing HDAC1. Front Oncol. 2022;12:1021270.","journal-title":"Front Oncol"},{"issue":"3","key":"3326_CR68","first-page":"437","volume":"30","author":"Y Liu","year":"2023","unstructured":"Liu Y, Yang C, Chen S, Liu W, Liang J, He S, et al. Cancer-derived Exosomal miR-375 targets DIP2C and promotes osteoblastic metastasis and prostate cancer progression by regulating the Wnt signaling pathway. Cancer Gene Ther. 2023;30(3):437\u201349.","journal-title":"Cancer Gene Ther"},{"issue":"8","key":"3326_CR69","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/s12276-022-00837-6","volume":"54","author":"J Gan","year":"2022","unstructured":"Gan J, Liu S, Zhang Y, He L, Bai L, Liao R, et al. MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4\/STAT3 axis. Exp Mol Med. 2022;54(8):1290\u2013305.","journal-title":"Exp Mol Med"},{"issue":"4","key":"3326_CR70","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.gendis.2022.06.007","volume":"10","author":"F Zeng","year":"2023","unstructured":"Zeng F, Zhao C, Wang R, Ren L, Qiu H, Zou Z, et al. Antagonizing Exosomal miR-18a-5p derived from prostate cancer cells ameliorates metastasis-induced osteoblastic lesions by targeting Hist1h2bc and activating Wnt\/beta-catenin pathway. Genes Dis. 2023;10(4):1626\u201340.","journal-title":"Genes Dis"},{"issue":"1","key":"3326_CR71","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41420-022-01163-6","volume":"8","author":"S Wang","year":"2022","unstructured":"Wang S, Du P, Cao Y, Ma J, Yang X, Yu Z, et al. Cancer associated fibroblasts secreted Exosomal miR-1290 contributes to prostate cancer cell growth and metastasis via targeting GSK3beta. Cell Death Discov. 2022;8(1):371.","journal-title":"Cell Death Discov"},{"issue":"1","key":"3326_CR72","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s10528-022-10251-2","volume":"61","author":"G Huang","year":"2023","unstructured":"Huang G, Jiang Z, Zhu W, Wu Z. Exosomal circKDM4A induces CUL4B to promote prostate cancer cell malignancy in a mir-338-3p-dependent manner. Biochem Genet. 2023;61(1):390\u2013409.","journal-title":"Biochem Genet"},{"issue":"2","key":"3326_CR73","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/aja202351","volume":"26","author":"Z Yang","year":"2023","unstructured":"Yang Z, Chen JQ, Liu TJ, Chen YL, Ma ZK, Fan YZ, et al. Knocking down AR promotes osteoblasts to recruit prostate cancer cells by altering Exosomal circ-DHPS\/miR-214-3p\/CCL5 pathway. Asian J Androl. 2023;26(2):195\u2013204.","journal-title":"Asian J Androl"},{"issue":"8","key":"3326_CR74","doi-asserted-by":"publisher","first-page":"e3376","DOI":"10.1002\/jgm.3376","volume":"24","author":"G Zhang","year":"2022","unstructured":"Zhang G, Liu Y, Yang J, Wang H, Xing Z. Inhibition of circ_0081234 reduces prostate cancer tumor growth and metastasis via the miR-1\/MAP 3 K1 axis. J Gene Med. 2022;24(8):e3376.","journal-title":"J Gene Med"},{"issue":"1","key":"3326_CR75","doi-asserted-by":"publisher","first-page":"e1156","DOI":"10.1002\/ctm2.1156","volume":"13","author":"L Ding","year":"2023","unstructured":"Ding L, Zheng Q, Lin Y, Wang R, Wang H, Luo W, et al. Exosome-derived circTFDP2 promotes prostate cancer progression by preventing PARP1 from caspase-3-dependent cleavage. Clin Transl Med. 2023;13(1):e1156.","journal-title":"Clin Transl Med"},{"key":"3326_CR76","doi-asserted-by":"publisher","first-page":"24922","DOI":"10.1038\/srep24922","volume":"6","author":"A Ahadi","year":"2016","unstructured":"Ahadi A, Brennan S, Kennedy PJ, Hutvagner G, Tran N. Long non-coding RNAs harboring MiRNA seed regions are enriched in prostate cancer exosomes. Sci Rep. 2016;6:24922.","journal-title":"Sci Rep"},{"issue":"12","key":"3326_CR77","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/s41419-021-04421-0","volume":"12","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Zhao H, Chen Y, Li K, Li T, Chen J, et al. Exosomal long noncoding RNA HOXD-AS1 promotes prostate cancer metastasis via miR-361-5p\/FOXM1 axis. Cell Death Dis. 2021;12(12):1129.","journal-title":"Cell Death Dis"},{"issue":"8","key":"3326_CR78","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1002\/ctm2.493","volume":"11","author":"C Mo","year":"2021","unstructured":"Mo C, Huang B, Zhuang J, Jiang S, Guo S, Mao X. LncRNA nuclear-enriched abundant transcript 1 shuttled by prostate cancer cells-secreted exosomes initiates osteoblastic phenotypes in the bone metastatic microenvironment via miR-205-5p\/runt-related transcription factor 2\/splicing factor proline- and glutamine-rich\/polypyrimidine tract-binding protein 2 axis. Clin Transl Med. 2021;11(8):e493.","journal-title":"Clin Transl Med"},{"issue":"23","key":"3326_CR79","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1080\/15384101.2021.1992853","volume":"20","author":"Q Li","year":"2021","unstructured":"Li Q, Hu J, Shi Y, Xiao M, Bi T, Wang C, et al. Exosomal lncAY927529 enhances prostate cancer cell proliferation and invasion through regulating bone microenvironment. Cell Cycle. 2021;20(23):2531\u201346.","journal-title":"Cell Cycle"},{"issue":"4","key":"3326_CR80","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/pros.23132","volume":"76","author":"L Rauschenberger","year":"2016","unstructured":"Rauschenberger L, Staar D, Thom K, Scharf C, Venz S, Homuth G, et al. Exosomal particles secreted by prostate cancer cells are potent mRNA and protein vehicles for the interference of tumor and tumor environment. Prostate. 2016;76(4):409\u201324.","journal-title":"Prostate"},{"issue":"5","key":"3326_CR81","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/jcb.21923","volume":"105","author":"J Hakulinen","year":"2008","unstructured":"Hakulinen J, Sankkila L, Sugiyama N, Lehti K, Keski-Oja J. Secretion of active membrane type 1 matrix metalloproteinase (MMP-14) into extracellular space in microvesicular exosomes. J Cell Biochem. 2008;105(5):1211\u20138.","journal-title":"J Cell Biochem"},{"issue":"3","key":"3326_CR82","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/mc.23157","volume":"59","author":"G Deep","year":"2020","unstructured":"Deep G, Jain A, Kumar A, Agarwal C, Kim S, Leevy WM, et al. Exosomes secreted by prostate cancer cells under hypoxia promote matrix metalloproteinases activity at pre-metastatic niches. Mol Carcinog. 2020;59(3):323\u201332.","journal-title":"Mol Carcinog"},{"key":"3326_CR83","doi-asserted-by":"crossref","unstructured":"Huertas-Larez R, Munoz-Moreno L, Recio-Aldavero J, Roman ID, Arenas MI, Blasco A, et al. Induction of more aggressive tumoral phenotypes in LNCaP and PC3 cells by serum exosomes from prostate cancer patients. Int J Cancer. 2023;153:1829\u201341.","DOI":"10.1002\/ijc.34673"},{"issue":"1","key":"3326_CR84","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12967-022-03860-3","volume":"21","author":"P Liu","year":"2023","unstructured":"Liu P, Wang W, Wang F, Fan J, Guo J, Wu T, et al. Alterations of plasma Exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer. J Transl Med. 2023;21(1):40.","journal-title":"J Transl Med"},{"key":"3326_CR85","doi-asserted-by":"crossref","unstructured":"Gaballa R, Ali HEA, Mahmoud MO, Rhim JS, Ali HI, Salem HF, et al. Exosomes-mediated transfer of itga2 promotes migration and invasion of prostate cancer cells by inducing epithelial-mesenchymal transition. Cancers (Basel). 2020;12(8).","DOI":"10.3390\/cancers12082300"},{"issue":"11","key":"3326_CR86","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41419-019-2066-3","volume":"10","author":"CJ Lin","year":"2019","unstructured":"Lin CJ, Yun EJ, Lo UG, Tai YL, Deng S, Hernandez E, et al. The paracrine induction of prostate cancer progression by caveolin-1. Cell Death Dis. 2019;10(11):834.","journal-title":"Cell Death Dis"},{"issue":"8","key":"3326_CR87","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1158\/0008-5472.CAN-08-4635","volume":"69","author":"Y Xu","year":"2009","unstructured":"Xu Y, Josson S, Fang F, Oberley TD, St Clair DK, Wan XS, et al. RelB enhances prostate cancer growth: implications for the role of the nuclear factor-kappaB alternative pathway in tumorigenicity. Cancer Res. 2009;69(8):3267\u201371.","journal-title":"Cancer Res"},{"key":"3326_CR88","doi-asserted-by":"publisher","first-page":"110221","DOI":"10.1016\/j.cellsig.2021.110221","volume":"91","author":"W Li","year":"2022","unstructured":"Li W, Xu J, Cheng L, Zhao C, Zhang L, Shao Q, et al. RelB promotes the migration and invasion of prostate cancer DU145 cells via Exosomal ICAM1 in vitro. Cell Signal. 2022;91:110221.","journal-title":"Cell Signal"},{"issue":"19","key":"3326_CR89","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1038\/s41388-020-1270-z","volume":"39","author":"J Liu","year":"2020","unstructured":"Liu J, He D, Cheng L, Huang C, Zhang Y, Rao X, et al. p300\/CBP Inhibition enhances the efficacy of programmed death-ligand 1 Blockade treatment in prostate cancer. Oncogene. 2020;39(19):3939\u201351.","journal-title":"Oncogene"},{"issue":"6","key":"3326_CR90","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.1002\/ctm2.204","volume":"10","author":"S Lin","year":"2020","unstructured":"Lin S, Zhou S, Yuan T. The sugar-coated bullets of cancer: Tumor-derived exosome surface glycosylation from basic knowledge to applications. Clin Transl Med. 2020;10(6):e204.","journal-title":"Clin Transl Med"},{"issue":"13","key":"3326_CR91","doi-asserted-by":"publisher","first-page":"8166","DOI":"10.1074\/jbc.M114.621383","volume":"290","author":"ME Hung","year":"2015","unstructured":"Hung ME, Leonard JN. Stabilization of exosome-targeting peptides via engineered glycosylation. J Biol Chem. 2015;290(13):8166\u201372.","journal-title":"J Biol Chem"},{"issue":"10","key":"3326_CR92","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1136\/jclinpath-2016-204312","volume":"70","author":"T Vermassen","year":"2017","unstructured":"Vermassen T, D\u2019Herde K, Jacobus D, Van Praet C, Poelaert F, Lumen N, et al. Release of urinary extracellular vesicles in prostate cancer is associated with altered urinary N-glycosylation profile. J Clin Pathol. 2017;70(10):838\u201346.","journal-title":"J Clin Pathol"},{"issue":"3","key":"3326_CR93","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3892\/ijo.2014.2256","volume":"44","author":"T Liu","year":"2014","unstructured":"Liu T, Mendes DE, Berkman CE. Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells. Int J Oncol. 2014;44(3):918\u201322.","journal-title":"Int J Oncol"},{"issue":"6","key":"3326_CR94","doi-asserted-by":"publisher","first-page":"101950","DOI":"10.1016\/j.jbc.2022.101950","volume":"298","author":"K Kondo","year":"2022","unstructured":"Kondo K, Harada Y, Nakano M, Suzuki T, Fukushige T, Hanzawa K, et al. Identification of distinct N-glycosylation patterns on extracellular vesicles from small-cell and non-small-cell lung cancer cells. J Biol Chem. 2022;298(6):101950.","journal-title":"J Biol Chem"},{"issue":"1","key":"3326_CR95","doi-asserted-by":"publisher","first-page":"1790159","DOI":"10.1080\/20013078.2020.1790159","volume":"9","author":"JP Flemming","year":"2020","unstructured":"Flemming JP, Hill BL, Haque MW, Raad J, Bonder CS, Harshyne LA, et al. miRNA- and cytokine-associated extracellular vesicles mediate squamous cell carcinomas. J Extracell Vesicles. 2020;9(1):1790159.","journal-title":"J Extracell Vesicles"},{"issue":"8","key":"3326_CR96","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1002\/ijc.32312","volume":"145","author":"D Kyuno","year":"2019","unstructured":"Kyuno D, Zhao K, Schnolzer M, Provaznik J, Hackert T, Zoller M. Claudin7-dependent exosome-promoted reprogramming of nonmetastasizing tumor cells. Int J Cancer. 2019;145(8):2182\u2013200.","journal-title":"Int J Cancer"},{"issue":"1","key":"3326_CR97","doi-asserted-by":"publisher","first-page":"1764192","DOI":"10.1080\/20013078.2020.1764192","volume":"9","author":"J Mariscal","year":"2020","unstructured":"Mariscal J, Vagner T, Kim M, Zhou B, Chin A, Zandian M, et al. Comprehensive palmitoyl-proteomic analysis identifies distinct protein signatures for large and small cancer-derived extracellular vesicles. J Extracell Vesicles. 2020;9(1):1764192.","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"3326_CR98","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1038\/s41467-021-22163-7","volume":"12","author":"X Shangguan","year":"2021","unstructured":"Shangguan X, He J, Ma Z, Zhang W, Ji Y, Shen K, et al. SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis. Nat Commun. 2021;12(1):1812.","journal-title":"Nat Commun"},{"key":"3326_CR99","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.bbrc.2022.12.015","volume":"641","author":"D Wen","year":"2023","unstructured":"Wen D, Hu M, Guo W, Wu J, Wu Y. Multi-SUMOylation of NAC1 is essential for the growth of prostate cancer cells. Biochem Biophys Res Commun. 2023;641:148\u201354.","journal-title":"Biochem Biophys Res Commun"},{"key":"3326_CR100","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1038\/ncomms3980","volume":"4","author":"C Villarroya-Beltri","year":"2013","unstructured":"Villarroya-Beltri C, Gutierrez-Vazquez C, Sanchez-Cabo F, Perez-Hernandez D, Vazquez J, Martin-Cofreces N, et al. Sumoylated hnRNPA2B1 controls the sorting of MiRNAs into exosomes through binding to specific motifs. Nat Commun. 2013;4:2980.","journal-title":"Nat Commun"},{"key":"3326_CR101","doi-asserted-by":"crossref","unstructured":"Wang W, Kong P, Feng K, Liu C, Gong X, Sun T, et al. Exosomal miR-222-3p contributes to castration-resistant prostate cancer by activating mTOR signaling. Cancer Sci. 2023;114:4252\u201369.","DOI":"10.1111\/cas.15948"},{"issue":"2","key":"3326_CR102","doi-asserted-by":"publisher","first-page":"878","DOI":"10.7150\/thno.49186","volume":"11","author":"Y Wang","year":"2021","unstructured":"Wang Y, Fang YX, Dong B, Du X, Wang J, Wang X, et al. Discovery of extracellular vesicles derived miR-181a-5p in patient\u2019s serum as an indicator for bone-metastatic prostate cancer. Theranostics. 2021;11(2):878\u201392.","journal-title":"Theranostics"},{"key":"3326_CR103","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.canlet.2021.11.017","volume":"526","author":"J Wang","year":"2022","unstructured":"Wang J, Du X, Wang X, Xiao H, Jing N, Xue W, et al. Tumor-derived miR-378a-3p-containing extracellular vesicles promote osteolysis by activating the Dyrk1a\/Nfatc1\/Angptl2 axis for bone metastasis. Cancer Lett. 2022;526:76\u201390.","journal-title":"Cancer Lett"},{"issue":"4","key":"3326_CR104","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/cbin.11303","volume":"44","author":"Y Zheng","year":"2020","unstructured":"Zheng Y, Li JX, Chen CJ, Lin ZY, Liu JX, Lin FJ. Extracellular vesicle-derived circ_SLC19A1 promotes prostate cancer cell growth and invasion through the miR-497\/septin 2 pathway. Cell Biol Int. 2020;44(4):1037\u201345.","journal-title":"Cell Biol Int"},{"issue":"8","key":"3326_CR105","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1016\/j.ymthe.2017.04.016","volume":"25","author":"P Gu","year":"2017","unstructured":"Gu P, Chen X, Xie R, Han J, Xie W, Wang B, et al. LncRNA HOXD-AS1 regulates proliferation and chemo-resistance of castration-resistant prostate cancer via recruiting WDR5. Mol Ther. 2017;25(8):1959\u201373.","journal-title":"Mol Ther"},{"issue":"11","key":"3326_CR106","doi-asserted-by":"publisher","first-page":"113424","DOI":"10.1016\/j.celrep.2023.113424","volume":"42","author":"F Xu","year":"2023","unstructured":"Xu F, Wang X, Huang Y, Zhang X, Sun W, Du Y, et al. Prostate cancer cell-derived Exosomal IL-8 fosters immune evasion by disturbing glucolipid metabolism of CD8(+) T cell. Cell Rep. 2023;42(11):113424.","journal-title":"Cell Rep"},{"key":"3326_CR107","doi-asserted-by":"publisher","first-page":"862015","DOI":"10.3389\/fonc.2022.862015","volume":"12","author":"X Jiang","year":"2022","unstructured":"Jiang X, Guo S, Xu M, Ma B, Liu R, Xu Y, et al. TFAP2C-mediated LncRNA PCAT1 inhibits ferroptosis in Docetaxel-resistant prostate cancer through c-Myc\/miR-25-3p\/SLC7A11 signaling. Front Oncol. 2022;12:862015.","journal-title":"Front Oncol"},{"issue":"1","key":"3326_CR108","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41392-023-01365-z","volume":"8","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang Y, Yang Y, Weng L, Wu Q, Zhang J, et al. Emerging phagocytosis checkpoints in cancer immunotherapy. Signal Transduct Target Ther. 2023;8(1):104.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"3326_CR109","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bcmd.2005.07.001","volume":"35","author":"AJ Abusamra","year":"2005","unstructured":"Abusamra AJ, Zhong Z, Zheng X, Li M, Ichim TE, Chin JL, et al. Tumor exosomes expressing Fas ligand mediate CD8\u2009+\u2009T-cell apoptosis. Blood Cells Mol Dis. 2005;35(2):169\u201373.","journal-title":"Blood Cells Mol Dis"},{"issue":"9","key":"3326_CR110","doi-asserted-by":"publisher","first-page":"e108925","DOI":"10.1371\/journal.pone.0108925","volume":"9","author":"M Lundholm","year":"2014","unstructured":"Lundholm M, Schroder M, Nagaeva O, Baranov V, Widmark A, Mincheva-Nilsson L, et al. Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8\u2009+\u2009T cells: mechanism of immune evasion. PLoS ONE. 2014;9(9):e108925.","journal-title":"PLoS ONE"},{"issue":"8","key":"3326_CR111","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1002\/1878-0261.13422","volume":"17","author":"YC Lu","year":"2023","unstructured":"Lu YC, Ho CH, Hong JH, Kuo MC, Liao YA, Jaw FS, et al. NKG2A and Circulating extracellular vesicles are key regulators of natural killer cell activity in prostate cancer after prostatectomy. Mol Oncol. 2023;17(8):1613\u201327.","journal-title":"Mol Oncol"},{"issue":"1","key":"3326_CR112","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/imm.12874","volume":"154","author":"D Guo","year":"2018","unstructured":"Guo D, Chen Y, Wang S, Yu L, Shen Y, Zhong H, et al. Exosomes from heat-stressed tumour cells inhibit tumour growth by converting regulatory T cells to Th17 cells via IL-6. Immunology. 2018;154(1):132\u201343.","journal-title":"Immunology"},{"issue":"15","key":"3326_CR113","doi-asserted-by":"publisher","first-page":"16405","DOI":"10.1002\/cam4.6275","volume":"12","author":"D Li","year":"2023","unstructured":"Li D, Zhou X, Xu W, Chen Y, Mu C, Zhao X, et al. Prostate cancer cells synergistically defend against CD8(+) T cells by secreting Exosomal PD-L1. Cancer Med. 2023;12(15):16405\u201315.","journal-title":"Cancer Med"},{"issue":"1","key":"3326_CR114","doi-asserted-by":"publisher","first-page":"1368823","DOI":"10.1080\/20013078.2017.1368823","volume":"6","author":"J Salimu","year":"2017","unstructured":"Salimu J, Webber J, Gurney M, Al-Taei S, Clayton A, Tabi Z. Dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes. J Extracell Vesicles. 2017;6(1):1368823.","journal-title":"J Extracell Vesicles"},{"issue":"7","key":"3326_CR115","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/ijc.28174","volume":"133","author":"G Chitadze","year":"2013","unstructured":"Chitadze G, Lettau M, Bhat J, Wesch D, Steinle A, Furst D, et al. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the a disintegrin and metalloproteases 10 and 17. Int J Cancer. 2013;133(7):1557\u201366.","journal-title":"Int J Cancer"},{"issue":"2","key":"3326_CR116","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.bbcan.2018.07.003","volume":"1870","author":"NM Namee","year":"2018","unstructured":"Namee NM, O\u2019Driscoll L. Extracellular vesicles and anti-cancer drug resistance. Biochim Biophys Acta Rev Cancer. 2018;1870(2):123\u201336.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"3326_CR117","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/mc.23129","volume":"59","author":"TC Peak","year":"2020","unstructured":"Peak TC, Panigrahi GK, Praharaj PP, Su Y, Shi L, Chyr J, et al. Syntaxin 6-mediated exosome secretion regulates enzalutamide resistance in prostate cancer. Mol Carcinog. 2020;59(1):62\u201372.","journal-title":"Mol Carcinog"},{"issue":"3","key":"3326_CR118","doi-asserted-by":"publisher","first-page":"612","DOI":"10.20517\/cdr.2022.26","volume":"5","author":"A Kumar","year":"2022","unstructured":"Kumar A, Kumar P, Sharma M, Kim S, Singh S, Kridel SJ, et al. Role of extracellular vesicles secretion in Paclitaxel resistance of prostate cancer cells. Cancer Drug Resist. 2022;5(3):612\u201324.","journal-title":"Cancer Drug Resist"},{"issue":"1","key":"3326_CR119","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13046-020-01570-6","volume":"39","author":"S Tan","year":"2020","unstructured":"Tan S, Xia L, Yi P, Han Y, Tang L, Pan Q, et al. Exosomal MiRNAs in tumor microenvironment. J Exp Clin Cancer Res. 2020;39(1):67.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"3326_CR120","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3892\/ijo.2016.3560","volume":"49","author":"J Li","year":"2016","unstructured":"Li J, Yang X, Guan H, Mizokami A, Keller ET, Xu X, et al. Exosome-derived MicroRNAs contribute to prostate cancer chemoresistance. Int J Oncol. 2016;49(2):838\u201346.","journal-title":"Int J Oncol"},{"issue":"8","key":"3326_CR121","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.7150\/thno.53412","volume":"11","author":"B Chen","year":"2021","unstructured":"Chen B, Sang Y, Song X, Zhang D, Wang L, Zhao W, et al. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28. Theranostics. 2021;11(8):3932\u201347.","journal-title":"Theranostics"},{"issue":"2","key":"3326_CR122","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.bbrc.2019.05.120","volume":"515","author":"Z Cao","year":"2019","unstructured":"Cao Z, Xu L, Zhao S. Exosome-derived miR-27a produced by PSC-27 cells contributes to prostate cancer chemoresistance through p53. Biochem Biophys Res Commun. 2019;515(2):345\u201351.","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"3326_CR123","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1038\/s12276-020-0431-z","volume":"52","author":"G Shan","year":"2020","unstructured":"Shan G, Gu J, Zhou D, Li L, Cheng W, Wang Y, et al. Cancer-associated fibroblast-secreted Exosomal miR-423-5p promotes chemotherapy resistance in prostate cancer by targeting GREM2 through the TGF-beta signaling pathway. Exp Mol Med. 2020;52(11):1809\u201322.","journal-title":"Exp Mol Med"},{"issue":"12","key":"3326_CR124","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nrurol.2016.220","volume":"13","author":"A Fenner","year":"2016","unstructured":"Fenner A. Prostate cancer: Exosomal AR-V7 is a marker of hormonal therapy resistance. Nat Rev Urol. 2016;13(12):695.","journal-title":"Nat Rev Urol"},{"issue":"4","key":"3326_CR125","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.eururo.2016.08.012","volume":"71","author":"M Del Re","year":"2017","unstructured":"Del Re M, Biasco E, Crucitta S, Derosa L, Rofi E, Orlandini C, et al. The detection of androgen receptor splice variant 7 in plasma-derived Exosomal Rna strongly predicts resistance to hormonal therapy in metastatic prostate cancer patients. Eur Urol. 2017;71(4):680\u20137.","journal-title":"Eur Urol"},{"key":"3326_CR126","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.omtn.2021.07.021","volume":"25","author":"DW Binzel","year":"2021","unstructured":"Binzel DW, Guo S, Yin H, Lee TJ, Liu S, Shu D, et al. Rational design for controlled release of Dicer-substrate SiRNA harbored in phi29 pRNA-based nanoparticles. Mol Therapy Nucleic Acids. 2021;25:524\u201335.","journal-title":"Mol Therapy Nucleic Acids"},{"issue":"5","key":"3326_CR127","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/cac2.12291","volume":"42","author":"D Hu","year":"2022","unstructured":"Hu D, Li Z, Zheng B, Lin X, Pan Y, Gong P, et al. Cancer-associated fibroblasts in breast cancer: challenges and opportunities. Cancer Commun (Lond). 2022;42(5):401\u201334.","journal-title":"Cancer Commun (Lond)"},{"issue":"2","key":"3326_CR128","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ccell.2020.06.005","volume":"38","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Karthaus WR, Lee YS, Gao VR, Wu C, Russo JW, et al. Tumor microenvironment-derived NRG1 promotes antiandrogen resistance in prostate cancer. Cancer Cell. 2020;38(2):279\u201396. e9.","journal-title":"Cancer Cell"},{"issue":"1","key":"3326_CR129","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20(1):131.","journal-title":"Mol Cancer"},{"issue":"12","key":"3326_CR130","doi-asserted-by":"publisher","first-page":"e12150","DOI":"10.1002\/jev2.12150","volume":"10","author":"AP Shephard","year":"2021","unstructured":"Shephard AP, Giles P, Mbengue M, Alraies A, Spary LK, Kynaston H, et al. Stroma-derived extracellular vesicle mRNA signatures inform histological nature of prostate cancer. J Extracell Vesicles. 2021;10(12):e12150.","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"3326_CR131","doi-asserted-by":"publisher","first-page":"188456","DOI":"10.1016\/j.bbcan.2020.188456","volume":"1875","author":"M Shelton","year":"2021","unstructured":"Shelton M, Anene CA, Nsengimana J, Roberts W, Newton-Bishop J, Boyne JR. The role of CAF derived Exosomal MicroRNAs in the tumour microenvironment of melanoma. Biochim Biophys Acta Rev Cancer. 2021;1875(1):188456.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"3326_CR132","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.gpb.2015.02.001","volume":"13","author":"J Zhang","year":"2015","unstructured":"Zhang J, Li S, Li L, Li M, Guo C, Yao J, et al. Exosome and Exosomal MicroRNA: trafficking, sorting, and function. Genomics Proteom Bioinf. 2015;13(1):17\u201324.","journal-title":"Genomics Proteom Bioinf"},{"issue":"5","key":"3326_CR133","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.eururo.2021.12.039","volume":"81","author":"Q Cheng","year":"2022","unstructured":"Cheng Q, Butler W, Zhou Y, Zhang H, Tang L, Perkinson K, et al. Pre-existing castration-resistant prostate cancer-like cells in primary prostate cancer promote resistance to hormonal therapy. Eur Urol. 2022;81(5):446\u201355.","journal-title":"Eur Urol"},{"issue":"1","key":"3326_CR134","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s13046-020-01761-1","volume":"39","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhao J, Ding M, Su Y, Cui D, Jiang C, et al. Loss of Exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis. J Exp Clin Cancer Res. 2020;39(1):282.","journal-title":"J Exp Clin Cancer Res"},{"issue":"21","key":"3326_CR135","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1038\/onc.2014.212","volume":"34","author":"S Josson","year":"2015","unstructured":"Josson S, Gururajan M, Sung SY, Hu P, Shao C, Zhau HE, et al. Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis. Oncogene. 2015;34(21):2690\u20139.","journal-title":"Oncogene"},{"key":"3326_CR136","doi-asserted-by":"publisher","first-page":"e10250","DOI":"10.7554\/eLife.10250","volume":"5","author":"H Zhao","year":"2016","unstructured":"Zhao H, Yang L, Baddour J, Achreja A, Bernard V, Moss T, et al. Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism. Elife. 2016;5:e10250.","journal-title":"Elife"},{"issue":"4","key":"3326_CR137","first-page":"199","volume":"20","author":"L Stone","year":"2023","unstructured":"Stone L. Singling out the immune-suppressive TME in prostate cancer. Nat Rev Urol. 2023;20(4):199.","journal-title":"Nat Rev Urol"},{"issue":"2","key":"3326_CR138","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/path.5757","volume":"255","author":"LB Andersen","year":"2021","unstructured":"Andersen LB, Norgaard M, Rasmussen M, Fredsoe J, Borre M, Ulhoi BP, et al. Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factors. J Pathol. 2021;255(2):155\u201365.","journal-title":"J Pathol"},{"key":"3326_CR139","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2021.10.027","volume":"525","author":"C Wang","year":"2022","unstructured":"Wang C, Zhang Y, Gao WQ. The evolving role of immune cells in prostate cancer. Cancer Lett. 2022;525:9\u201321.","journal-title":"Cancer Lett"},{"key":"3326_CR140","unstructured":"Guan han. Sun wenyan, Wang sheng, zhijun C. Mechanism of miR-374a encapsulation in M2 macrophage exosomes promotes malignant progression of prostate cancer. Journal of Bengbu Medical College. 2023; 48(6):701\u2013\u200911."},{"issue":"1","key":"3326_CR141","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12967-022-03494-5","volume":"20","author":"F Gao","year":"2022","unstructured":"Gao F, Xu Q, Tang Z, Zhang N, Huang Y, Li Z, et al. Exosomes derived from myeloid-derived suppressor cells facilitate castration-resistant prostate cancer progression via S100A9\/circMID1\/miR-506-3p\/MID1. J Transl Med. 2022;20(1):346.","journal-title":"J Transl Med"},{"issue":"5","key":"3326_CR142","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1002\/anie.201912524","volume":"59","author":"W Nie","year":"2020","unstructured":"Nie W, Wu G, Zhang J, Huang LL, Ding J, Jiang A, et al. Responsive exosome nano-bioconjugates for synergistic cancer therapy. Angew Chem Int Ed Engl. 2020;59(5):2018\u201322.","journal-title":"Angew Chem Int Ed Engl"},{"key":"3326_CR143","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jconrel.2022.01.026","volume":"343","author":"X Huang","year":"2022","unstructured":"Huang X, Wu W, Jing D, Yang L, Guo H, Wang L, et al. Engineered exosome as targeted LncRNA MEG3 delivery vehicles for osteosarcoma therapy. J Control Release. 2022;343:107\u201317.","journal-title":"J Control Release"},{"issue":"1","key":"3326_CR144","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s12276-023-01132-8","volume":"56","author":"I Jung","year":"2024","unstructured":"Jung I, Shin S, Baek MC, Yea K. Modification of immune cell-derived exosomes for enhanced cancer immunotherapy: current advances and therapeutic applications. Exp Mol Med. 2024;56(1):19\u201331.","journal-title":"Exp Mol Med"},{"issue":"11","key":"3326_CR145","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/pros.23996","volume":"80","author":"X Shi","year":"2020","unstructured":"Shi X, Sun J, Li H, Lin H, Xie W, Li J, et al. Antitumor efficacy of interferon-gamma-modified Exosomal vaccine in prostate cancer. Prostate. 2020;80(11):811\u201323.","journal-title":"Prostate"},{"key":"3326_CR146","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.2147\/IJN.S304515","volume":"16","author":"ZW Luo","year":"2021","unstructured":"Luo ZW, Xia K, Liu YW, Liu JH, Rao SS, Hu XK, et al. Extracellular vesicles from Akkermansia muciniphila elicit antitumor immunity against prostate cancer via modulation of CD8(+) T cells and macrophages. Int J Nanomed. 2021;16:2949\u201363.","journal-title":"Int J Nanomed"},{"key":"3326_CR147","doi-asserted-by":"publisher","first-page":"k3519","DOI":"10.1136\/bmj.k3519","volume":"362","author":"D Ilic","year":"2018","unstructured":"Ilic D, Djulbegovic M, Jung JH, Hwang EC, Zhou Q, Cleves A, et al. Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis. BMJ. 2018;362:k3519.","journal-title":"BMJ"},{"issue":"10","key":"3326_CR148","doi-asserted-by":"publisher","first-page":"e46737","DOI":"10.1371\/journal.pone.0046737","volume":"7","author":"S Khan","year":"2012","unstructured":"Khan S, Jutzy JM, Valenzuela MM, Turay D, Aspe JR, Ashok A, et al. Plasma-derived Exosomal survivin, a plausible biomarker for early detection of prostate cancer. PLoS ONE. 2012;7(10):e46737.","journal-title":"PLoS ONE"},{"issue":"1","key":"3326_CR149","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12885-017-3301-x","volume":"17","author":"K Kawakami","year":"2017","unstructured":"Kawakami K, Fujita Y, Matsuda Y, Arai T, Horie K, Kameyama K, et al. Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer. BMC Cancer. 2017;17(1):316.","journal-title":"BMC Cancer"},{"issue":"1","key":"3326_CR150","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s40364-024-00685-8","volume":"12","author":"X Qin","year":"2024","unstructured":"Qin X, Niu R, Tan Y, Huang Y, Ren W, Zhou W, et al. Exosomal PSM-E inhibits macrophage M2 polarization to suppress prostate cancer metastasis through the RACK1 signaling axis. Biomark Res. 2024;12(1):138.","journal-title":"Biomark Res"},{"issue":"1","key":"3326_CR151","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12943-021-01349-z","volume":"20","author":"J Ji","year":"2021","unstructured":"Ji J, Chen R, Zhao L, Xu Y, Cao Z, Xu H, et al. Circulating Exosomal mRNA profiling identifies novel signatures for the detection of prostate cancer. Mol Cancer. 2021;20(1):58.","journal-title":"Mol Cancer"},{"issue":"3","key":"3326_CR152","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/1878-0261.13329","volume":"17","author":"L Schneider","year":"2023","unstructured":"Schneider L, Dansranjav T, Neumann E, Yan H, Pilatz A, Schuppe HC, et al. Post-prostatic-massage urine exosomes of men with chronic prostatitis\/chronic pelvic pain syndrome carry prostate-cancer-typical MicroRNAs and activate proto-oncogenes. Mol Oncol. 2023;17(3):445\u201368.","journal-title":"Mol Oncol"},{"issue":"1","key":"3326_CR153","doi-asserted-by":"publisher","first-page":"13772","DOI":"10.1038\/s41598-019-50172-6","volume":"9","author":"M Barcelo","year":"2019","unstructured":"Barcelo M, Castells M, Bassas L, Vigues F, Larriba S. Semen MiRNAs contained in exosomes as non-invasive biomarkers for prostate cancer diagnosis. Sci Rep. 2019;9(1):13772.","journal-title":"Sci Rep"},{"key":"3326_CR154","doi-asserted-by":"publisher","first-page":"602493","DOI":"10.3389\/fcell.2020.602493","volume":"8","author":"T Guo","year":"2020","unstructured":"Guo T, Wang Y, Jia J, Mao X, Stankiewicz E, Scandura G, et al. The identification of plasma Exosomal mir-423-3p as a potential predictive biomarker for prostate cancer castration-resistance development by plasma Exosomal Mirna sequencing. Front Cell Dev Biol. 2020;8:602493.","journal-title":"Front Cell Dev Biol"},{"key":"3326_CR155","doi-asserted-by":"publisher","first-page":"110113","DOI":"10.1016\/j.cellsig.2021.110113","volume":"87","author":"MP Rode","year":"2021","unstructured":"Rode MP, Silva AH, Cisilotto J, Rosolen D, Creczynski-Pasa TB. miR-425-5p as an Exosomal biomarker for metastatic prostate cancer. Cell Signal. 2021;87:110113.","journal-title":"Cell Signal"},{"key":"3326_CR156","doi-asserted-by":"crossref","unstructured":"Cruz-Burgos M, Cortes-Ramirez SA, Losada-Garcia A, Morales-Pacheco M, Martinez-Martinez E, Morales-Montor JG, et al. Unraveling the role of EV-derived mir-150-5p in prostate cancer metastasis and its association with high-grade Gleason scores: implications for diagnosis. Cancers (Basel). 2023;15(16).","DOI":"10.3390\/cancers15164148"},{"key":"3326_CR157","doi-asserted-by":"crossref","unstructured":"Temilola DO, Wium M, Paccez J, Salukazana AS, Otu HH, Carbone GM, et al. Potential of MiRNAs in plasma extracellular vesicle for the stratification of prostate cancer in a South African population. Cancers (Basel). 2023;15(15).","DOI":"10.3390\/cancers15153968"},{"key":"3326_CR158","doi-asserted-by":"publisher","first-page":"5369","DOI":"10.2147\/IJGM.S361981","volume":"15","author":"Z Lu","year":"2022","unstructured":"Lu Z, Hou J, Li X, Zhou J, Luo B, Liang S, et al. Exosome-derived MiRNAs as potential biomarkers for prostate bone metastasis. Int J Gen Med. 2022;15:5369\u201383.","journal-title":"Int J Gen Med"},{"issue":"8","key":"3326_CR159","doi-asserted-by":"publisher","first-page":"e3042","DOI":"10.1002\/jmr.3042","volume":"36","author":"G Ashok","year":"2023","unstructured":"Ashok G, Das R, Anbarasu A, Ramaiah S. Comprehensive analysis on the diagnostic role of circulatory exosome-based miR-92a-3p for osteoblastic metastases in prostate adenocarcinoma. J Mol Recognit. 2023;36(8):e3042.","journal-title":"J Mol Recognit"},{"issue":"1","key":"3326_CR160","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41525-021-00212-w","volume":"6","author":"S Shin","year":"2021","unstructured":"Shin S, Park YH, Jung SH, Jang SH, Kim MY, Lee JY, et al. Urinary exosome MicroRNA signatures as a noninvasive prognostic biomarker for prostate cancer. NPJ Genom Med. 2021;6(1):45.","journal-title":"NPJ Genom Med"},{"issue":"12","key":"3326_CR161","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1002\/ijc.29664","volume":"137","author":"D Duijvesz","year":"2015","unstructured":"Duijvesz D, Versluis CY, van der Fels CA, Vredenbregt-van den Berg MS, Leivo J, Peltola MT, et al. Immuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer. Int J Cancer. 2015;137(12):2869\u201378.","journal-title":"Int J Cancer"},{"issue":"6","key":"3326_CR162","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.eururo.2018.08.019","volume":"74","author":"J McKiernan","year":"2018","unstructured":"McKiernan J, Donovan MJ, Margolis E, Partin A, Carter B, Brown G, et al. A prospective adaptive utility trial to validate performance of a novel urine exosome gene expression assay to predict high-grade prostate cancer in patients with prostate-specific antigen 2-10ng\/ml at initial biopsy. Eur Urol. 2018;74(6):731\u20138.","journal-title":"Eur Urol"},{"issue":"7","key":"3326_CR163","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1001\/jamaoncol.2016.0097","volume":"2","author":"J McKiernan","year":"2016","unstructured":"McKiernan J, Donovan MJ, O\u2019Neill V, Bentink S, Noerholm M, Belzer S, et al. A novel urine exosome gene expression assay to predict high-grade prostate cancer at initial biopsy. JAMA Oncol. 2016;2(7):882\u20139.","journal-title":"JAMA Oncol"},{"issue":"11","key":"3326_CR164","doi-asserted-by":"publisher","first-page":"e870","DOI":"10.1093\/oncolo\/oyac177","volume":"27","author":"S Zhu","year":"2022","unstructured":"Zhu S, Ni Y, Wang Z, Zhang X, Zhang Y, Zhao F, et al. Plasma Exosomal AKR1C3 mRNa expression is a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer. Oncologist. 2022;27(11):e870\u20137.","journal-title":"Oncologist"},{"issue":"2","key":"3326_CR165","doi-asserted-by":"publisher","first-page":"15","DOI":"10.31083\/j.fbs1402015","volume":"14","author":"EA Pudova","year":"2022","unstructured":"Pudova EA, Kobelyatskaya AA, Katunina IV, Snezhkina AV, Fedorova MS, Guvatova ZG, et al. Dynamic profiling of Exosomal Micrornas in blood plasma of patients with castration-resistant prostate cancer. Front Biosci (Schol Ed). 2022;14(2):15.","journal-title":"Front Biosci (Schol Ed)"},{"issue":"1","key":"3326_CR166","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.eururo.2014.07.035","volume":"67","author":"X Huang","year":"2015","unstructured":"Huang X, Yuan T, Liang M, Du M, Xia S, Dittmar R, et al. Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer. Eur Urol. 2015;67(1):33\u201341.","journal-title":"Eur Urol"},{"key":"3326_CR167","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.matbio.2018.08.004","volume":"77","author":"SR Krishn","year":"2019","unstructured":"Krishn SR, Singh A, Bowler N, Duffy AN, Friedman A, Fedele C, et al. Prostate cancer sheds the alphavbeta3 integrin in vivo through exosomes. Matrix Biol. 2019;77:41\u201357.","journal-title":"Matrix Biol"},{"issue":"11","key":"3326_CR168","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1158\/1541-7786.MCR-16-0058","volume":"14","author":"A Singh","year":"2016","unstructured":"Singh A, Fedele C, Lu H, Nevalainen MT, Keen JH, Languino LR. Exosome-mediated transfer of \u0391v\u03b23 integrin from tumorigenic to nontumorigenic cells promotes a migratory phenotype. Mol Cancer Res. 2016;14(11):1136\u201346.","journal-title":"Mol Cancer Res"},{"issue":"4","key":"3326_CR169","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.juro.2013.11.001","volume":"191","author":"S Dijkstra","year":"2014","unstructured":"Dijkstra S, Birker IL, Smit FP, Leyten GH, de Reijke TM, van Oort IM, et al. Prostate cancer biomarker profiles in urinary sediments and exosomes. J Urol. 2014;191(4):1132\u20138.","journal-title":"J Urol"},{"key":"3326_CR170","doi-asserted-by":"publisher","first-page":"115380","DOI":"10.1016\/j.bios.2023.115380","volume":"235","author":"H Liang","year":"2023","unstructured":"Liang H, Wang X, Li F, Xie Y, Shen J, Wang X, et al. Label-free plasmonic metasensing of PSA and exosomes in serum for rapid high-sensitivity diagnosis of early prostate cancer. Biosens Bioelectron. 2023;235:115380.","journal-title":"Biosens Bioelectron"},{"issue":"1","key":"3326_CR171","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1038\/s41467-019-11486-1","volume":"10","author":"D Wu","year":"2019","unstructured":"Wu D, Yan J, Shen X, Sun Y, Thulin M, Cai Y, et al. Profiling surface proteins on individual exosomes using a proximity barcoding assay. Nat Commun. 2019;10(1):3854.","journal-title":"Nat Commun"},{"issue":"12","key":"3326_CR172","doi-asserted-by":"publisher","first-page":"14693","DOI":"10.1021\/acsami.1c22569","volume":"14","author":"Q Li","year":"2022","unstructured":"Li Q, Wang Y, Xue Y, Qiao L, Yu G, Liu Y, et al. Ultrasensitive analysis of exosomes using a 3D self-assembled nanostructured SiO2 microfluidic chip. ACS Appl Mater Interfaces. 2022;14(12):14693\u2013702.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3326_CR173","doi-asserted-by":"publisher","first-page":"113504","DOI":"10.1016\/j.bios.2021.113504","volume":"192","author":"J Kim","year":"2021","unstructured":"Kim J, Shim JS, Han BH, Kim HJ, Park J, Cho IJ, et al. Hydrogel-based hybridization chain reaction (HCR) for detection of urinary Exosomal MiRNAs as a diagnostic tool of prostate cancer. Biosens Bioelectron. 2021;192:113504.","journal-title":"Biosens Bioelectron"},{"key":"3326_CR174","doi-asserted-by":"crossref","unstructured":"Song J, Cho MH, Cho H, Song Y, Lee SW, Nam HC, et al. Amplifying mutational profiling of extracellular vesicle mRNA with SCOPE. Nat Biotechnol. 2024.","DOI":"10.1038\/s41587-024-02426-6"},{"issue":"7","key":"3326_CR175","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1021\/acs.molpharmaceut.3c00299","volume":"20","author":"Q Guo","year":"2023","unstructured":"Guo Q, Zhao C, Gao X, Ding L, Wang P, Ren Y, et al. One-minute iodine isotope labeling technology enables noninvasive tracking and quantification of extracellular vesicles in tumor lesions and intact animals. Mol Pharm. 2023;20(7):3672\u201382.","journal-title":"Mol Pharm"},{"issue":"5","key":"3326_CR176","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.7150\/thno.92621","volume":"14","author":"Y Liu","year":"2024","unstructured":"Liu Y, Li M, Liu H, Kang C, Wang C. Cancer diagnosis using label-free SERS-based exosome analysis. Theranostics. 2024;14(5):1966\u201381.","journal-title":"Theranostics"},{"key":"3326_CR177","doi-asserted-by":"publisher","first-page":"114116","DOI":"10.1016\/j.bios.2022.114116","volume":"205","author":"WH Kim","year":"2022","unstructured":"Kim WH, Lee JU, Jeon MJ, Park KH, Sim SJ. Three-dimensional hierarchical plasmonic nano-architecture based label-free surface-enhanced Raman spectroscopy detection of urinary Exosomal MiRNA for clinical diagnosis of prostate cancer. Biosens Bioelectron. 2022;205:114116.","journal-title":"Biosens Bioelectron"},{"issue":"4","key":"3326_CR178","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1021\/acsami.9b21333","volume":"12","author":"S Dong","year":"2020","unstructured":"Dong S, Wang Y, Liu Z, Zhang W, Yi K, Zhang X, et al. Beehive-inspired macroporous SERS probe for cancer detection through capturing and analyzing exosomes in plasma. ACS Appl Mater Interfaces. 2020;12(4):5136\u201346.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"3","key":"3326_CR179","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1083\/jcb.201010021","volume":"192","author":"M Yu","year":"2011","unstructured":"Yu M, Stott S, Toner M, Maheswaran S, Haber DA. Circulating tumor cells: approaches to isolation and characterization. J Cell Biol. 2011;192(3):373\u201382.","journal-title":"J Cell Biol"},{"issue":"4","key":"3326_CR180","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.annonc.2021.01.074","volume":"32","author":"W Yu","year":"2021","unstructured":"Yu W, Hurley J, Roberts D, Chakrabortty SK, Enderle D, Noerholm M, et al. Exosome-based liquid biopsies in cancer: opportunities and challenges. Ann Oncol. 2021;32(4):466\u201377.","journal-title":"Ann Oncol"},{"issue":"1","key":"3326_CR181","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12943-022-01509-9","volume":"21","author":"D Yu","year":"2022","unstructured":"Yu D, Li Y, Wang M, Gu J, Xu W, Cai H, et al. Exosomes as a new frontier of cancer liquid biopsy. Mol Cancer. 2022;21(1):56.","journal-title":"Mol Cancer"},{"issue":"1","key":"3326_CR182","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12943-024-02215-4","volume":"24","author":"J Li","year":"2025","unstructured":"Li J, Wang J, Chen Z. Emerging role of exosomes in cancer therapy: progress and challenges. Mol Cancer. 2025;24(1):13.","journal-title":"Mol Cancer"},{"issue":"5","key":"3326_CR183","doi-asserted-by":"publisher","first-page":"8043","DOI":"10.18632\/oncotarget.13302","volume":"8","author":"I Dean","year":"2017","unstructured":"Dean I, Dzinic SH, Bernardo MM, Zou Y, Kimler V, Li X, et al. The secretion and biological function of tumor suppressor Maspin as an exosome cargo protein. Oncotarget. 2017;8(5):8043\u201356.","journal-title":"Oncotarget"},{"key":"3326_CR184","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jconrel.2020.12.017","volume":"330","author":"M Severic","year":"2021","unstructured":"Severic M, Ma G, Pereira SGT, Ruiz A, Cheung CCL, Al-Jamal WT. Genetically-engineered anti-PSMA exosome mimetics targeting advanced prostate cancer in vitro and in vivo. J Control Release. 2021;330:101\u201310.","journal-title":"J Control Release"},{"issue":"1","key":"3326_CR185","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/smll.201302143","volume":"10","author":"AH Alhasan","year":"2014","unstructured":"Alhasan AH, Patel PC, Choi CH, Mirkin CA. Exosome encased spherical nucleic acid gold nanoparticle conjugates as potent MicroRNA regulation agents. Small. 2014;10(1):186\u201392.","journal-title":"Small"},{"key":"3326_CR186","doi-asserted-by":"publisher","first-page":"120946","DOI":"10.1016\/j.biomaterials.2021.120946","volume":"275","author":"S Pan","year":"2021","unstructured":"Pan S, Zhang Y, Huang M, Deng Z, Zhang A, Pei L, et al. Urinary exosomes-based engineered nanovectors for homologously targeted chemo-chemodynamic prostate cancer therapy via abrogating EGFR\/AKT\/NF-kB\/IkB signaling. Biomaterials. 2021;275:120946.","journal-title":"Biomaterials"},{"issue":"1","key":"3326_CR187","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12865-022-00514-3","volume":"23","author":"Y Peng","year":"2022","unstructured":"Peng Y, Zhao M, Hu Y, Guo H, Zhang Y, Huang Y, et al. Blockade of exosome generation by GW4869 inhibits the education of M2 macrophages in prostate cancer. BMC Immunol. 2022;23(1):37.","journal-title":"BMC Immunol"},{"issue":"1","key":"3326_CR188","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1080\/10717544.2022.2044937","volume":"29","author":"D Wang","year":"2022","unstructured":"Wang D, Wan Z, Yang Q, Chen J, Liu Y, Lu F, et al. Sonodynamical reversion of immunosuppressive microenvironment in prostate cancer via engineered exosomes. Drug Deliv. 2022;29(1):702\u201313.","journal-title":"Drug Deliv"},{"key":"3326_CR189","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.actbio.2022.01.005","volume":"141","author":"JH Lee","year":"2022","unstructured":"Lee JH, Song J, Kim IG, You G, Kim H, Ahn JH, et al. Exosome-mediated delivery of transforming growth factor-beta receptor 1 kinase inhibitors and toll-like receptor 7\/8 agonists for combination therapy of tumors. Acta Biomater. 2022;141:354\u201363.","journal-title":"Acta Biomater"},{"key":"3326_CR190","doi-asserted-by":"publisher","first-page":"114445","DOI":"10.1016\/j.bios.2022.114445","volume":"213","author":"J Bu","year":"2022","unstructured":"Bu J, Jeong WJ, Jafari R, Kubiatowicz LJ, Nair A, Poellmann MJ, et al. Bimodal liquid biopsy for cancer immunotherapy based on peptide engineering and nanoscale analysis. Biosens Bioelectron. 2022;213:114445.","journal-title":"Biosens Bioelectron"},{"issue":"1","key":"3326_CR191","first-page":"77","volume":"12","author":"E Cha","year":"2010","unstructured":"Cha E, Fong L. Therapeutic vaccines for prostate cancer. Curr Opin Mol Ther. 2010;12(1):77\u201385.","journal-title":"Curr Opin Mol Ther"},{"issue":"15","key":"3326_CR192","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.1158\/0008-5472.CAN-10-4076","volume":"71","author":"RB Rountree","year":"2011","unstructured":"Rountree RB, Mandl SJ, Nachtwey JM, Dalpozzo K, Do L, Lombardo JR, et al. Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacy. Cancer Res. 2011;71(15):5235\u201344.","journal-title":"Cancer Res"},{"issue":"5","key":"3326_CR193","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1001294","volume":"363","author":"PW Kantoff","year":"2010","unstructured":"Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med. 2010;363(5):411\u201322.","journal-title":"N Engl J Med"},{"issue":"1","key":"3326_CR194","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41392-023-01704-0","volume":"9","author":"F Tan","year":"2024","unstructured":"Tan F, Li X, Wang Z, Li J, Shahzad K, Zheng J. Clinical applications of stem cell-derived exosomes. Signal Transduct Target Ther. 2024;9(1):17.","journal-title":"Signal Transduct Target Ther"},{"key":"3326_CR195","doi-asserted-by":"crossref","unstructured":"Tang J, Chen Y, Wang C, Xia Y, Yu T, Tang M, et al. The role of mesenchymal stem cells in cancer and prospects for their use in cancer therapeutics. MedComm (2020). 2024;5(8):e663.","DOI":"10.1002\/mco2.663"},{"issue":"4","key":"3326_CR196","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.bbrc.2018.04.038","volume":"499","author":"TC Peak","year":"2018","unstructured":"Peak TC, Praharaj PP, Panigrahi GK, Doyle M, Su Y, Schlaepfer IR, et al. Exosomes secreted by placental stem cells selectively inhibit growth of aggressive prostate cancer cells. Biochem Biophys Res Commun. 2018;499(4):1004\u201310.","journal-title":"Biochem Biophys Res Commun"},{"key":"3326_CR197","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.2147\/IJN.S200036","volume":"14","author":"F Vakhshiteh","year":"2019","unstructured":"Vakhshiteh F, Atyabi F, Ostad SN. Mesenchymal stem cell exosomes: a two-edged sword in cancer therapy. Int J Nanomed. 2019;14:2847\u201359.","journal-title":"Int J Nanomed"},{"issue":"5","key":"3326_CR198","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s13402-017-0335-7","volume":"40","author":"K Pakravan","year":"2017","unstructured":"Pakravan K, Babashah S, Sadeghizadeh M, Mowla SJ, Mossahebi-Mohammadi M, Ataei F, et al. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR\/HIF-1alpha\/VEGF signaling axis in breast cancer cells. Cell Oncol (Dordr). 2017;40(5):457\u201370.","journal-title":"Cell Oncol (Dordr)"},{"issue":"3","key":"3326_CR199","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/stem.2298","volume":"34","author":"JD Anderson","year":"2016","unstructured":"Anderson JD, Johansson HJ, Graham CS, Vesterlund M, Pham MT, Bramlett CS, et al. Comprehensive proteomic analysis of mesenchymal stem cell exosomes reveals modulation of angiogenesis via nuclear factor-KappaB signaling. Stem Cells. 2016;34(3):601\u201313.","journal-title":"Stem Cells"},{"issue":"28","key":"3326_CR200","doi-asserted-by":"publisher","first-page":"44462","DOI":"10.18632\/oncotarget.9852","volume":"7","author":"F Alcayaga-Miranda","year":"2016","unstructured":"Alcayaga-Miranda F, Gonzalez PL, Lopez-Verrilli A, Varas-Godoy M, Aguila-Diaz C, Contreras L, et al. Prostate tumor-induced angiogenesis is blocked by exosomes derived from menstrual stem cells through the Inhibition of reactive oxygen species. Oncotarget. 2016;7(28):44462\u201377.","journal-title":"Oncotarget"},{"issue":"1","key":"3326_CR201","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1158\/0008-5472.CAN-09-2021","volume":"70","author":"M Sachdeva","year":"2010","unstructured":"Sachdeva M, Mo YY. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res. 2010;70(1):378\u201387.","journal-title":"Cancer Res"},{"issue":"17","key":"3326_CR202","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1089\/scd.2016.0093","volume":"25","author":"K Takahara","year":"2016","unstructured":"Takahara K, Ii M, Inamoto T, Nakagawa T, Ibuki N, Yoshikawa Y, et al. MicroRNA-145 mediates the inhibitory effect of adipose tissue-derived stromal cells on prostate cancer. Stem Cells Dev. 2016;25(17):1290\u20138.","journal-title":"Stem Cells Dev"},{"issue":"1","key":"3326_CR203","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1186\/s13046-019-1488-1","volume":"38","author":"S Jiang","year":"2019","unstructured":"Jiang S, Mo C, Guo S, Zhuang J, Huang B, Mao X. Human bone marrow mesenchymal stem cells-derived microRNA-205-containing exosomes impede the progression of prostate cancer through suppression of RHPN2. J Exp Clin Cancer Res. 2019;38(1):495.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"3326_CR204","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13046-022-02417-y","volume":"41","author":"S Jiang","year":"2022","unstructured":"Jiang S, Mo C, Guo S, Zhuang J, Huang B, Mao X, Correction. Human bone marrow mesenchymal stem cells-derived microRNA-205-containing exosomes impede the progression of prostate cancer through suppression of RHPN2. J Exp Clin Cancer Res. 2022;41(1):206.","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"3326_CR205","doi-asserted-by":"publisher","first-page":"256","DOI":"10.31083\/j.fbl2709256","volume":"27","author":"I Kurniawati","year":"2022","unstructured":"Kurniawati I, Liu MC, Hsieh CL, Do AD, Sung SY. Targeting castration-resistant prostate cancer using mesenchymal stem cell exosomes for therapeutic microRNA-let-7c delivery. Front Biosci (Landmark Ed). 2022;27(9):256.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"2","key":"3326_CR206","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1080\/21655979.2021.2009416","volume":"13","author":"S Jiang","year":"2022","unstructured":"Jiang S, Chen H, He K, Wang J. Human bone marrow mesenchymal stem cells-derived exosomes attenuated prostate cancer progression via the miR-99b-5p\/IGF1R axis. Bioengineered. 2022;13(2):2004\u201316.","journal-title":"Bioengineered"},{"issue":"1","key":"3326_CR207","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15384047.2022.2123675","volume":"23","author":"C Li","year":"2022","unstructured":"Li C, Sun Z, Song Y, Zhang Y. Suppressive function of bone marrow-derived mesenchymal stem cell-derived Exosomal microRNA-187 in prostate cancer. Cancer Biol Ther. 2022;23(1):1\u201314.","journal-title":"Cancer Biol Ther"},{"key":"3326_CR208","doi-asserted-by":"publisher","first-page":"102078","DOI":"10.1016\/j.tice.2023.102078","volume":"82","author":"X Wu","year":"2023","unstructured":"Wu X, Zeng Z, Peng K, Ren D, Zhang L. Regulatory mechanism of DHRS2-modified human umbilical cord mesenchymal stem cells-derived exosomes in prostate cancer cell proliferation and apoptosis. Tissue Cell. 2023;82:102078.","journal-title":"Tissue Cell"},{"issue":"1","key":"3326_CR209","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13287-020-02097-5","volume":"12","author":"Q Zhao","year":"2021","unstructured":"Zhao Q, Hai B, Kelly J, Wu S, Liu F. Extracellular vesicle mimics made from iPS cell-derived mesenchymal stem cells improve the treatment of metastatic prostate cancer. Stem Cell Res Ther. 2021;12(1):29.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3326_CR210","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s13287-021-02404-8","volume":"12","author":"S Yang","year":"2021","unstructured":"Yang S, Liang X, Song J, Li C, Liu A, Luo Y, et al. A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6. Stem Cell Res Ther. 2021;12(1):315.","journal-title":"Stem Cell Res Ther"},{"key":"3326_CR211","doi-asserted-by":"publisher","first-page":"122542","DOI":"10.1016\/j.lfs.2024.122542","volume":"342","author":"H Padinharayil","year":"2024","unstructured":"Padinharayil H, Varghese J, Wilson C, George A. Mesenchymal stem cell-derived exosomes: characteristics and applications in disease pathology and management. Life Sci. 2024;342:122542.","journal-title":"Life Sci"},{"issue":"2","key":"3326_CR212","first-page":"109","volume":"39","author":"Y Tian","year":"2023","unstructured":"Tian Y, Guo X, Cheng J, Wang P. Exosomes derived from mesenchymal stem cells loaded with Annexin A2 reduce the polarization of M2 macrophages to inhibit the growth of prostate cancer cells in nude mice. J Cell Mol Immunol. 2023;39(2):109\u201316.","journal-title":"J Cell Mol Immunol"},{"key":"3326_CR213","doi-asserted-by":"publisher","first-page":"112056","DOI":"10.1016\/j.bios.2020.112056","volume":"154","author":"S Wang","year":"2020","unstructured":"Wang S, Khan A, Huang R, Ye S, Di K, Xiong T, et al. Recent advances in single extracellular vesicle detection methods. Biosens Bioelectron. 2020;154:112056.","journal-title":"Biosens Bioelectron"},{"key":"3326_CR214","doi-asserted-by":"crossref","unstructured":"Lim M, Shin H, Jeong H, Kwon Y, Kim M, Lee J, et al. Diagnosis of prostate cancer metastasis via extracellular vesicles isolated using two-phase interface as membrane-less filter. Small. 2024;20(52):2404846.","DOI":"10.1002\/smll.202404846"},{"issue":"22","key":"3326_CR215","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.1016\/j.cell.2023.09.012","volume":"186","author":"J Wolf","year":"2023","unstructured":"Wolf J, Rasmussen DK, Sun YJ, Vu JT, Wang E, Espinosa C, et al. Liquid-biopsy proteomics combined with AI identifies cellular drivers of eye aging and disease in vivo. Cell. 2023;186(22):4868\u201384. e12.","journal-title":"Cell"},{"issue":"12","key":"3326_CR216","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/cac2.12204","volume":"41","author":"J Yang","year":"2021","unstructured":"Yang J, Xu R, Wang C, Qiu J, Ren B, You L. Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review. Cancer Commun (Lond). 2021;41(12):1257\u201374.","journal-title":"Cancer Commun (Lond)"},{"key":"3326_CR217","doi-asserted-by":"publisher","first-page":"116773","DOI":"10.1016\/j.bios.2024.116773","volume":"267","author":"JY Choi","year":"2025","unstructured":"Choi JY, Park S, Shim JS, Park HJ, Kuh SU, Jeong Y, et al. Explainable artificial intelligence-driven prostate cancer screening using Exosomal multi-marker based dual-gate FET biosensor. Biosens Bioelectron. 2025;267:116773.","journal-title":"Biosens Bioelectron"},{"issue":"4","key":"3326_CR218","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41587-023-01825-5","volume":"42","author":"T Sych","year":"2024","unstructured":"Sych T, Schlegel J, Barriga HMG, Ojansivu M, Hanke L, Weber F, et al. High-throughput measurement of the content and properties of nano-sized bioparticles with single-particle profiler. Nat Biotechnol. 2024;42(4):587\u201390.","journal-title":"Nat Biotechnol"},{"key":"3326_CR219","doi-asserted-by":"crossref","unstructured":"Correction to. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles. 2024;13(5):e12451.","DOI":"10.1002\/jev2.12451"},{"issue":"14","key":"3326_CR220","doi-asserted-by":"publisher","first-page":"e12182","DOI":"10.1002\/jev2.12182","volume":"10","author":"KW Witwer","year":"2021","unstructured":"Witwer KW, Goberdhan DC, O\u2019Driscoll L, Thery C, Welsh JA, Blenkiron C, et al. Updating MISEV: evolving the minimal requirements for studies of extracellular vesicles. J Extracell Vesicles. 2021;10(14):e12182.","journal-title":"J Extracell Vesicles"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03326-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03326-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03326-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T22:01:03Z","timestamp":1742594463000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03326-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":220,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3326"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03326-w","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,21]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"230"}}